Disclosure Statement

You must select "I Understand" to see results.

The physicians in our directory are members of a Children’s Health hospital medical staff or are credentialed by Children’s Health for managed care participation. Some physicians are employed by Children’s Health, some are employed elsewhere, and some maintain an independent medical practice. There is no fee for being listed in our directory. The physicians populating your search results are selected based on the criteria that you provide and are then listed alphabetically. If a physician is no longer on a Children’s Health medical staff or participating in a Children’s Health managed care agreement, he/she would not be eligible to be listed in our directory.

Stanton Carl Goldman, MD $$

Pediatric Hematologist/Oncologist

Languages Spoken:
English,

Education and Training

Medical School
Boston University School of Medicine (1990)
Residency
Childrens National Medical Center - DC (1993), General Practice
Fellowship
Johns Hopkins Univ School of Medicine - Hemo (1996), Pediatric Hematology/Oncology
Board Certification
American Board of Pediatrics/Hematology-Oncology

Departments and Programs

Hematology/Oncology
  • Publications

    • Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia:  a Children’s Oncology Group report. British Journal of Haematology, 2014
    • Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma:  a Children’s Oncology Group report. Leukemia, 2013
    • Translocation associated primitive round cell sarcoma: report of a case and review of the literature. Pediatric and Developmental Pathology, 2007
    • A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk of tumor lysis. Blood, 2001